VolitionRx Ltd; VolitionRx Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluat...
VolitionRx Ltd; VolitionRx Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating NuQ(R) Assays in Most Prevalent Cancers
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
2015 MAY 20 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, announced that it has accelerated its large independent prospective study evaluating its proprietary N...
Alternative Titles
Full title
VolitionRx Ltd; VolitionRx Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating NuQ(R) Assays in Most Prevalent Cancers
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1680823857
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1680823857
Other Identifiers
ISSN
1535-2757
E-ISSN
1537-1395
